{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:12:58Z","timestamp":1767989578327,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,2,29]],"date-time":"2012-02-29T00:00:00Z","timestamp":1330473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00213-012-2661-9","type":"journal-article","created":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T16:14:08Z","timestamp":1330445648000},"page":"425-438","source":"Crossref","is-referenced-by-count":19,"title":["Interactions between dopamine transporter and cannabinoid receptor ligands in rhesus monkeys"],"prefix":"10.1007","volume":"222","author":[{"given":"David R.","family":"Schulze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Ivy","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance R.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,29]]},"reference":[{"key":"2661_CR1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0014-2999(95)00661-3","volume":"295","author":"JJ Anderson","year":"1996","unstructured":"Anderson JJ, Kask AM, Chase TN (1996) Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists. Eur J Pharmacol 295:163\u2013168","journal-title":"Eur J Pharmacol"},{"key":"2661_CR2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0149-7634(05)80051-X","volume":"16","author":"RL Balster","year":"1992","unstructured":"Balster RL, Prescott WR (1992) \u03949-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication. Neurosci Biobehav Rev 16:55\u201362","journal-title":"Neurosci Biobehav Rev"},{"key":"2661_CR3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0028-3908(03)00029-7","volume":"44","author":"JF Cheer","year":"2003","unstructured":"Cheer JF, Kendall DA, Mason R, Marsden CA (2003) Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum. Neuropharmacology 44:633\u2013641","journal-title":"Neuropharmacology"},{"key":"2661_CR4","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1523\/JNEUROSCI.0529-04.2004","volume":"24","author":"JF Cheer","year":"2004","unstructured":"Cheer JF, Wassum KM, Heien ML, Phillips PE, Wightman RM (2004) Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. J Neurosci 24:4393\u20134400","journal-title":"J Neurosci"},{"key":"2661_CR5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02245916","volume":"102","author":"JP Chen","year":"1990","unstructured":"Chen JP, Paredes W, Li J, Smith D, Lowinson J, Gardner EL (1990) \u03949-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology 102:156\u2013162","journal-title":"Psychopharmacology"},{"key":"2661_CR6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0022-3565(25)12911-X","volume":"277","author":"DR Compton","year":"1996","unstructured":"Compton DR, Aceto MD, Lowe J, Martin BR (1996) In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exp Ther 277:586\u2013594","journal-title":"J Pharmacol Exp Ther"},{"key":"2661_CR7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-007-1042-2","volume":"198","author":"DC D\u2019Souza","year":"2008","unstructured":"D\u2019Souza DC, Braley G, Blaise R, Vendetti M, Oliver S, Pittman B, Ranganathan M, Bhakta S, Zimolo Z, Cooper T, Perry E (2008) Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans. Psychopharmacology 198:587\u2013603","journal-title":"Psychopharmacology"},{"key":"2661_CR8","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1073\/pnas.95.17.10269","volume":"95","author":"M Diana","year":"1998","unstructured":"Diana M, Melis M, Muntoni AL, Gessa GL (1998) Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proc Natl Acad Sci USA 95:10269\u201310273","journal-title":"Proc Natl Acad Sci USA"},{"key":"2661_CR9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/cpt1976203350","volume":"20","author":"MA Evans","year":"1976","unstructured":"Evans MA, Martz R, Rodda BE, Lemberger L, Forney RB (1976) Effects of marihuana-dextroamphetamine combination. Clin Pharmacol Ther 20:350\u2013358","journal-title":"Clin Pharmacol Ther"},{"key":"2661_CR10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0091-3057(87)90506-5","volume":"28","author":"RW Foltin","year":"1987","unstructured":"Foltin RW, Fischman MW, Pedroso JJ, Pearlson GD (1987) Marijuana and cocaine interactions in humans: cardiovascular consequences. Pharmacol Biochem Behav 28:459\u2013464","journal-title":"Pharmacol Biochem Behav"},{"key":"2661_CR11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0376-8716(93)80001-U","volume":"32","author":"RW Foltin","year":"1993","unstructured":"Foltin RW, Fischman MW, Pippen PA, Kelly TH (1993) Behavioral effects of cocaine alone and in combination with ethanol or marijuana in humans. Drug Alcohol Depend 32:93\u2013106","journal-title":"Drug Alcohol Depend"},{"key":"2661_CR12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/BF00444694","volume":"98","author":"DV Gauvin","year":"1989","unstructured":"Gauvin DV, Young AM (1989) Evidence for perceptual masking of the discriminative morphine stimulus. Psychopharmacology 98:212\u2013221","journal-title":"Psychopharmacology"},{"key":"2661_CR13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(97)01442-8","volume":"341","author":"GL Gessa","year":"1998","unstructured":"Gessa GL, Melis M, Muntoni AL, Diana M (1998) Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur J Pharmacol 341:39\u201344","journal-title":"Eur J Pharmacol"},{"key":"2661_CR14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/7268","volume":"2","author":"A Giuffrida","year":"1999","unstructured":"Giuffrida A, Parsons LH, Kerr TM, Rodr\u00edguez de Fonseca F, Navarro M, Piomelli D (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 2:358\u2013363","journal-title":"Nat Neurosci"},{"key":"2661_CR15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0014-2999(98)00851-6","volume":"365","author":"MA Gorriti","year":"1999","unstructured":"Gorriti MA, Rodr\u00edguez de Fonseca F, Navarro M, Palomo T (1999) Chronic (\u2212)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats. Eur J Pharmacol 365:133\u2013142","journal-title":"Eur J Pharmacol"},{"key":"2661_CR16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s002130000657","volume":"155","author":"M Haney","year":"2001","unstructured":"Haney M, Ward AS, Comer SD, Hart CL, Foltin RW, Fischman MW (2001) Bupropion SR worsens mood during marijuana withdrawal in humans. Psychopharmacology 155:171\u2013179","journal-title":"Psychopharmacology"},{"key":"2661_CR17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00426776","volume":"54","author":"C Hattendorf","year":"1977","unstructured":"Hattendorf C, Hattendorf M, Coper H, Fernandes M (1977) Interaction between \u22069-tetrahydrocannabinol and d-amphetamine. Psychopharmacology 54:177\u2013182","journal-title":"Psychopharmacology"},{"key":"2661_CR18","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1126\/science.163.3874.1464","volume":"163","author":"D Holtzman","year":"1969","unstructured":"Holtzman D, Lovell RA, Jaffe JH, Freedman DX (1969) 1- \u03949-tetrahydrocannabinol: neurochemical and behavioral effects in the mouse. Science 163:1464\u20131467","journal-title":"Science"},{"key":"2661_CR19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0028-3908(84)90003-0","volume":"23","author":"TUC J\u00e4rbe","year":"1984","unstructured":"J\u00e4rbe TUC (1984) Discriminative stimulus properties of cocaine. Effects of apomorphine, haloperidol, procaine and other drugs. Neuropharmacology 23:899\u2013907","journal-title":"Neuropharmacology"},{"key":"2661_CR20","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0022-3565(25)24169-6","volume":"248","author":"JB Kamien","year":"1989","unstructured":"Kamien JB, Woolverton WL (1989) A pharmacological analysis of the discriminative stimulus properties of d-amphetamine in rhesus monkeys. J Pharmacol Exp Ther 248:938\u2013946","journal-title":"J Pharmacol Exp Ther"},{"key":"2661_CR21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.pbb.2008.03.032","volume":"90","author":"HL Kimmel","year":"2008","unstructured":"Kimmel HL, Negus SS, Wilcox KM, Ewing SB, Stehouwer J, Goodman MM, Votaw JR, Mello NK, Carroll FI, Howell LL (2008) Relationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeys. Pharmacol Biochem Behav 90:453\u2013462","journal-title":"Pharmacol Biochem Behav"},{"key":"2661_CR22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0022-3565(25)12606-2","volume":"254","author":"MS Kleven","year":"1990","unstructured":"Kleven MS, Anthony EW, Woolverton WL (1990) Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 254:312\u2013317","journal-title":"J Pharmacol Exp Ther"},{"key":"2661_CR23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-3565(25)30726-3","volume":"199","author":"BK Koe","year":"1976","unstructured":"Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199:649\u2013661","journal-title":"J Pharmacol Exp Ther"},{"key":"2661_CR24","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1021\/jm00018a004","volume":"38","author":"P Kotian","year":"1995","unstructured":"Kotian P, Abraham P, Lewin AH, Mascarella SW, Boja JW, Kuhar MJ, Carroll FI (1995) Synthesis and ligand binding study of 3 beta-(4\u2032-substituted phenyl)-2 beta-(heterocyclic)tropanes. J Med Chem 38:3451\u20133453","journal-title":"J Med Chem"},{"key":"2661_CR25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0376-8716(81)90104-6","volume":"8","author":"EO Lew","year":"1981","unstructured":"Lew EO, Richardson JS (1981) Neurochemical and behavioural correlates of the interaction between amphetamine and \u03949-tetrahydrocannabinol in the rat. Drug Alcohol Depend 8:93\u2013101","journal-title":"Drug Alcohol Depend"},{"key":"2661_CR26","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.neuropharm.2007.12.011","volume":"54","author":"D Marcellino","year":"2008","unstructured":"Marcellino D, Carriba P, Filip M, Borgkvist A, Frankowska M, Bellido I, Tanganelli S, M\u00fcller CE, Fisone G, Lluis C, Agnati LF, Franco R, Fuxe K (2008) Antagonistic cannabinoid CB1\/dopamine D2 receptor interactions in striatal CB1\/D2 heteromers. A combined neurochemical and behavioral analysis. Neuropharmacology 54:815\u2013823","journal-title":"Neuropharmacology"},{"key":"2661_CR27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00008877-199907000-00010","volume":"10","author":"JM Masserano","year":"1999","unstructured":"Masserano JM, Karoum F, Wyatt RJ (1999) SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine. Behav Pharmacol 10:429\u2013432","journal-title":"Behav Pharmacol"},{"key":"2661_CR28","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1124\/jpet.106.107110","volume":"319","author":"LR McMahon","year":"2006","unstructured":"McMahon LR (2006) Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating \u03949-tetrahydrocannabinol. J Pharmacol Exp Ther 319:1211\u20131218","journal-title":"J Pharmacol Exp Ther"},{"key":"2661_CR29","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1476-5381.2010.01116.x","volume":"162","author":"LR McMahon","year":"2010","unstructured":"McMahon LR (2010) Chronic \u03949-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids. Br J Pharmacol 162:1060\u20131073","journal-title":"Br J Pharmacol"},{"key":"2661_CR30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00210-008-0337-0","volume":"379","author":"D Moranta","year":"2009","unstructured":"Moranta D, Esteban S, Garc\u00eda-Sevilla JA (2009) Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain. Naunyn Schmiedebergs Arch Pharmacol 379:61\u201372","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2661_CR31","volume-title":"Guidelines for the care and use of mammals in neuroscience and behavioral research","author":"National Research Council","year":"2003","unstructured":"National Research Council (2003) Guidelines for the care and use of mammals in neuroscience and behavioral research. National Academies Press, Washington"},{"key":"2661_CR32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.0953-816x.2001.01612.x","volume":"14","author":"M Pistis","year":"2001","unstructured":"Pistis M, Porcu G, Melis M, Diana M, Gessa GL (2001) Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation. Eur J Neurosci 14:96\u2013102","journal-title":"Eur J Neurosci"},{"key":"2661_CR33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3565(25)32131-2","volume":"214","author":"MK Poddar","year":"1980","unstructured":"Poddar MK, Dewey WL (1980) Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes. J Pharmacol Exp Ther 214:63\u201367","journal-title":"J Pharmacol Exp Ther"},{"key":"2661_CR34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1471-4159.2006.03880.x","volume":"98","author":"M Solinas","year":"2006","unstructured":"Solinas M, Justinova Z, Goldberg SR, Tanda G (2006) Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats. J Neurochem 98:408\u2013419","journal-title":"J Neurochem"},{"key":"2661_CR35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-010-1789-8","volume":"209","author":"M Solinas","year":"2010","unstructured":"Solinas M, Tanda G, Wertheim CE, Goldberg SR (2010) Dopaminergic augmentation of \u03949-tetrahydrocannabinol (THC) discrimination: possible involvement of D2-induced formation of anandamide. Psychopharmacology 209:191\u2013202","journal-title":"Psychopharmacology"},{"key":"2661_CR36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1124\/jpet.110.168435","volume":"334","author":"JL Stewart","year":"2010","unstructured":"Stewart JL, McMahon LR (2010) Rimonabant-induced \u03949-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs. J Pharmacol Exp Ther 334:347\u2013356","journal-title":"J Pharmacol Exp Ther"},{"key":"2661_CR37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1201\/9781420036107","volume-title":"Drug synergism and dose\u2013effect data analysis","author":"RJ Tallarida","year":"2000","unstructured":"Tallarida RJ (2000) Drug synergism and dose\u2013effect data analysis. Chapman and Hall\/CRC, Boca Raton, pp 44\u201350"},{"key":"2661_CR38","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1126\/science.276.5321.2048","volume":"276","author":"G Tanda","year":"1997","unstructured":"Tanda G, Pontieri FE, Di Chiara G (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276:2048\u20132050","journal-title":"Science"},{"key":"2661_CR39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(99)00384-2","volume":"376","author":"G Tanda","year":"1999","unstructured":"Tanda G, Loddo P, Di Chiara G (1999) Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol. Eur J Pharmacol 376:23\u201326","journal-title":"Eur J Pharmacol"},{"key":"2661_CR40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1103\/PhysRev.23.266","volume":"23","author":"RL Wegel","year":"1924","unstructured":"Wegel RL, Lane CE (1924) The auditory masking of one pure tone by another and its probable relation to the dynamics of the inner ear. Physiol Rev 23:266\u2013285","journal-title":"Physiol Rev"},{"key":"2661_CR41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0028-3908(99)00140-9","volume":"39","author":"X Wu","year":"2000","unstructured":"Wu X, French ED (2000) Effects of chronic \u03949-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment. Neuropharmacology 39:391\u2013398","journal-title":"Neuropharmacology"},{"key":"2661_CR42","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1176\/ajp.130.6.707","volume":"130","author":"S Zalcman","year":"1973","unstructured":"Zalcman S, Liskow B, Cadoret R, Goodwin D (1973) Marijuana and amphetamine: the question of interaction. Am J Psychiatry 130:707\u2013708","journal-title":"Am J Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2661-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-012-2661-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2661-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T04:18:35Z","timestamp":1742617115000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-012-2661-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,29]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["2661"],"URL":"https:\/\/doi.org\/10.1007\/s00213-012-2661-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,29]]}}}